Q32 Bio Statistics Share Statistics Q32 Bio has 12.2M
shares outstanding. The number of shares has increased by 1.14%
in one year.
Shares Outstanding 12.2M Shares Change (YoY) 1.14% Shares Change (QoQ) 0% Owned by Institutions (%) 59.96% Shares Floating 4.44M Failed to Deliver (FTD) Shares 44,449 FTD / Avg. Volume 3.38%
Short Selling Information The latest short interest is 556.8K, so 4.56% of the outstanding
shares have been sold short.
Short Interest 556.8K Short % of Shares Out 4.56% Short % of Float 16.22% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.67 and the forward
PE ratio is -0.37.
Q32 Bio's PEG ratio is
0.01.
PE Ratio -0.67 Forward PE -0.37 PS Ratio 0 Forward PS 10.9 PB Ratio 5.65 P/FCF Ratio -0.47 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Q32 Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.97,
with a Debt / Equity ratio of 3.33.
Current Ratio 4.97 Quick Ratio 4.97 Debt / Equity 3.33 Debt / EBITDA -0.42 Debt / FCF -0.28 Interest Coverage -220.34
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.7M Employee Count 28 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 21K Effective Tax Rate -0.05%
Stock Price Statistics The stock price has increased by -95.01% in the
last 52 weeks. The beta is 0.01, so Q32 Bio's
price volatility has been higher than the market average.
Beta 0.01 52-Week Price Change -95.01% 50-Day Moving Average 1.89 200-Day Moving Average 8.5 Relative Strength Index (RSI) 40.85 Average Volume (20 Days) 1,315,291
Income Statement
Revenue n/a Gross Profit -487K Operating Income -66.1M Net Income -47.73M EBITDA -45.3M EBIT -45.79M Earnings Per Share (EPS) -5.12
Full Income Statement Balance Sheet The company has 77.97M in cash and 18.9M in
debt, giving a net cash position of 59.06M.
Cash & Cash Equivalents 77.97M Total Debt 18.9M Net Cash 59.06M Retained Earnings -234.81M Total Assets 66.12M Working Capital 46.79M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -67.72M
and capital expenditures -75K, giving a free cash flow of -67.79M.
Operating Cash Flow -67.72M Capital Expenditures -75K Free Cash Flow -67.79M FCF Per Share -7.27
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields QTTB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for QTTB is $12,
which is 570.4% higher than the current price. The consensus rating is "Hold".
Price Target $12 Price Target Difference 570.4% Analyst Consensus Hold Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 26, 2024. It was a
backward
split with a ratio of 1:18.
Last Split Date Mar 26, 2024 Split Type backward Split Ratio 1:18
Scores Altman Z-Score -6.01 Piotroski F-Score 2
